Did Pliant Therapeutics Beat Earnings?

Pliant Therapeutics (PLRX) reported Q2 '26 revenue of $0.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Pliant Therapeutics’s job postings, web traffic, and employee business outlook. See the full PLRX stock analysis or the earnings calendar for upcoming reports.

Pliant Therapeutics Quarterly Financial Trends ()

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue2.3M
Gross margin50.0%
Operating margin-2,348.9%
Net income-58M-50M-56M-43M-26M-24M-20M-22M
Net margin-2,190.8%
EPS

Pliant Therapeutics Earnings Trend Analysis

Over the eight quarters from Q3 '24 to Q2 '26, Pliant Therapeutics’s quarterly revenue moved from $0 to $0.

When Is Pliant Therapeutics’s Next Earnings Date?

Pliant Therapeutics reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the PLRX earnings calendar.

Frequently Asked Questions: Pliant Therapeutics Earnings

Pliant Therapeutics's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Pliant Therapeutics reported Q2 '26 revenue of $0.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the PLRX AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.